Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 13201-13250 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT04593394
Inducible Laryngeal Obstruction in Severe Asthma in Severe Asthma
N/AActive, not recruiting
160 participants
Started: Nov 1, 2020 · Completed: Oct 1, 2024
2 conditions1 sponsor1 location
NCT04545541
Nebulised Heparin in Patients With Severe COVID-19
PHASE2/PHASE3Active, not recruiting
57 participants
Started: Nov 1, 2020 · Completed: Jun 30, 2025
2 conditions1 sponsor1 location
NCT04235257
Intradermal, Fractional Dose of HPV Vaccines:
PHASE4Active, not recruiting
40 participants
Started: Nov 1, 2020 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT04619745
A Feasibility Study of Physical Activity After Surgical or Catheterization Intervention
NAActive, not recruiting
43 participants
Started: Nov 1, 2020 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT04727996
Phase II Study of Sitravatinib in Combination With Tislelizumab in Patients With Advanced Biliary Tract Cancer
PHASE2Active, not recruiting
43 participants
Started: Nov 1, 2020 · Completed: Dec 31, 2024
1 condition2 sponsors1 location
NCT04588051
Cabozantinib in Hepatocellular Carcinoma
PHASE2Active, not recruiting
20 participants
Started: Nov 1, 2020 · Completed: Dec 31, 2027
1 condition1 sponsor2 locations
NCT04680832
Exhaled Breath Analysis Using eNose Technology as a Biomarker for Diagnosis and Disease Progression in Fibrotic ILD
N/AActive, not recruiting
600 participants
Started: Nov 1, 2020 · Completed: Dec 31, 2026
1 condition1 sponsor5 locations
NCT04345757
After Cesarean Time Interval for Exercise (ACTIVE) Trial
NAActive, not recruiting
200 participants
Started: Nov 1, 2020 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT04587908
A Phase 3 Study of TAS-205 in Patients With Duchenne Muscular Dystrophy(REACH-DMD)
PHASE3Active, not recruiting
104 participants
Started: Nov 1, 2020 · Completed: May 31, 2027
1 condition1 sponsor5 locations
NCT06034964
Tislelizumab Combined With Chemotherapy in First-line Treatment of AGC
N/AActive, not recruiting
60 participants
Started: Nov 1, 2020 · Completed: Nov 1, 2025
4 conditions1 sponsor1 location
NCT04598035
Epidural Spinal Cord Stimulation for Hypertension in Patients With Neuropathic Pain
N/AActive, not recruiting
72 participants
Started: Nov 1, 2020 · Completed: Nov 1, 2025
3 conditions1 sponsor2 locations
NCT04833829
Cross-disciplinary HIV Integrated Mental Health Support Intervention
NAActive, not recruiting
850 participants
Started: Nov 1, 2020 · Completed: Sep 30, 2025
2 conditions2 sponsors2 locations
NCT04517214
Comparing Chemotherapy With/Without Toripalimab For Primary Metastatic Nasopharyngeal Carcinoma
PHASE2Active, not recruiting
100 participants
Started: Nov 1, 2020 · Completed: Dec 31, 2026
1 condition14 sponsors1 location
NCT03836378
Addition of Dehydrated Human Amnion-Chorion Membrane During Scaling and Root Planing
NAActive, not recruiting
250 participants
Started: Nov 1, 2020 · Completed: Nov 1, 2027
1 condition1 sponsor1 location
NCT04061980
Encorafenib and Binimetinib With or Without Nivolumab in Treating Patients With Metastatic Radioiodine Refractory BRAF V600 Mutant Thyroid Cancer
PHASE2Active, not recruiting
24 participants
Started: Oct 30, 2020 · Completed: Oct 30, 2027
7 conditions2 sponsors1 location
NCT04446962
LOC-R01 Study of Lenalidomide and Ibrutinib in Association With Rituximab-Methotrexate Procarbazine Vincristin (R-MPV)
PHASE1/PHASE2Active, not recruiting
118 participants
Started: Oct 30, 2020 · Completed: Aug 30, 2035
2 conditions2 sponsors28 locations
NCT04540211
A Study of Atezolizumab Plus Tiragolumab in Combination With Paclitaxel and Cisplatin Compared With Paclitaxel and Cisplatin as First-Line Treatment in Participants With Unresectable Locally Advanced, Unresectable Recurrent, or Metastatic Esophageal Carcinoma
PHASE3Active, not recruiting
461 participants
Started: Oct 30, 2020 · Completed: Jan 31, 2026
1 condition1 sponsor67 locations
NCT05557617
Periodontitis and Periodontal Bacteria in Dementia
N/AActive, not recruiting
120 participants
Started: Oct 30, 2020 · Completed: Dec 31, 2024
3 conditions1 sponsor1 location
NCT04417621
Study of Efficacy and Safety of LXH254 Combinations in Patients With Previously Treated Unresectable or Metastatic Melanoma
PHASE2Active, not recruiting
134 participants
Started: Oct 30, 2020 · Completed: Mar 27, 2026
1 condition1 sponsor36 locations
NCT04469231
The Synergy Disc To Anterior Cervical Discectomy and Fusion
NAActive, not recruiting
175 participants
Started: Oct 30, 2020 · Completed: Jan 1, 2026
1 condition2 sponsors19 locations
NCT05479929
Work of Breathing Assessment in Triage Scale
N/AActive, not recruiting
39 participants
Started: Oct 30, 2020 · Completed: Oct 31, 2025
5 conditions1 sponsor1 location
NCT06242171
Prognostic Indices of Atheromatosis Severity and Coronary Artery Bypass Surgery Outcomes for Patients With Coronary Artery Disease
N/AActive, not recruiting
90 participants
Started: Oct 30, 2020 · Completed: Aug 31, 2026
2 conditions1 sponsor1 location
NCT04358276
Technology-Enabled Activation of Skin Cancer Screening for Stem Cell Transplant Survivors and Their Primary Care Providers, TEACH Study
NAActive, not recruiting
840 participants
Started: Oct 30, 2020 · Completed: Mar 31, 2026
1 condition2 sponsors1 location
NCT04528680
Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma
PHASE1/PHASE2Active, not recruiting
57 participants
Started: Oct 29, 2020 · Completed: Nov 30, 2025
6 conditions4 sponsors1 location
NCT04603625
Postural Management for Hip Luxation in Quadriplegic Cerebral Palsy
NAActive, not recruiting
72 participants
Started: Oct 29, 2020 · Completed: Dec 31, 2025
1 condition10 sponsors1 location
NCT04467021
Cancer and Blood Pressure Management, CARISMA Study
NAActive, not recruiting
61 participants
Started: Oct 29, 2020 · Completed: Aug 31, 2026
9 conditions2 sponsors25 locations
NCT04918082
Assessment of Quality of Life and Treatment Times for Patients With Invasive Type Breast Cancer in Martinique
N/AActive, not recruiting
133 participants
Started: Oct 28, 2020 · Completed: Jun 28, 2026
3 conditions1 sponsor1 location
NCT04612309
Retrospective Study on the Use of Immunotherapy in Patients With MSI-H Metastatic Colorectal Cancer
N/AActive, not recruiting
100 participants
Started: Oct 28, 2020 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT04408313
Extended Release Naltrexone Versus Extended Release Buprenorphine with Individuals Leaving Jail
PHASE2/PHASE3Active, not recruiting
240 participants
Started: Oct 28, 2020 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04206969
Assessment of Transcultural Psychotherapy in Child Major Depressive Disorder
NAActive, not recruiting
80 participants
Started: Oct 28, 2020 · Completed: May 31, 2025
1 condition2 sponsors4 locations
NCT07204327
Atezolizumab Plus Bevacizumab Combined With Locoregional Therapies in Unresectable Hepatocellular Carcinoma (ISMIO-001)
N/AActive, not recruiting
1,136 participants
Started: Oct 28, 2020 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT04595565
Sacituzumab Govitecan in Primary HER2-negative Breast Cancer
PHASE3Active, not recruiting
1,332 participants
Started: Oct 28, 2020 · Completed: Mar 30, 2029
2 conditions7 sponsors163 locations
NCT04592393
Pancreas Cancer Surveillance Using an Abbreviated MRI
NAActive, not recruiting
200 participants
Started: Oct 28, 2020 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT05489250
The PLATON Network
N/AActive, not recruiting
1,000 participants
Started: Oct 28, 2020 · Completed: May 31, 2032
6 conditions1 sponsor31 locations
NCT04767594
First-line Palbociclib and Endocrine Therapy for Patients With HR+/HER2- Advanced Breast Cancer in the Real-world Setting.
N/AActive, not recruiting
1,409 participants
Started: Oct 27, 2020 · Completed: Apr 30, 2029
1 condition1 sponsor191 locations
NCT04619069
Intermittent Androgen Deprivation Therapy With or Without Stereotactic Body Radiotherapy for Molecularly Identified Hormone Sensitive Oligometastatic Prostate Cancer
PHASE1/PHASE2Active, not recruiting
60 participants
Started: Oct 27, 2020 · Completed: Oct 31, 2027
1 condition1 sponsor1 location
NCT04414163
A Study of IMC-001 in Subjects With Relapsed or Refractory Extranodal NK/T Cell Lymphoma, Nasal Type
PHASE2Active, not recruiting
23 participants
Started: Oct 27, 2020 · Completed: Feb 28, 2026
2 conditions1 sponsor5 locations
NCT04174105
Gene Transfer Study in Patients With Late Onset Pompe Disease
PHASE1/PHASE2Active, not recruiting
11 participants
Started: Oct 27, 2020 · Completed: Feb 28, 2030
1 condition1 sponsor4 locations
NCT04452591
Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin
PHASE3Active, not recruiting
190 participants
Started: Oct 27, 2020 · Completed: Dec 24, 2029
2 conditions1 sponsor72 locations
NCT05206448
Randomized Controlled Trial of Combined Letrozole and Clomid (CLC II) Versus Letrozole Alone for Women With Anovulation
PHASE4Active, not recruiting
190 participants
Started: Oct 26, 2020 · Completed: Dec 31, 2025
3 conditions4 sponsors4 locations
NCT04610671
Study of CG0070 Combined With Nivolumab in Cisplatin Ineligible Patients With MIBC
PHASE1Active, not recruiting
21 participants
Started: Oct 26, 2020 · Completed: Jan 31, 2026
2 conditions3 sponsors1 location
NCT05548166
Development of CELIAC-Q KIDS: A Patient-Reported Outcome Measure for Pediatric Celiac Disease
N/AActive, not recruiting
100 participants
Started: Oct 26, 2020 · Completed: Dec 31, 2026
3 conditions3 sponsors2 locations
NCT04544449
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis
PHASE3Active, not recruiting
985 participants
Started: Oct 26, 2020 · Completed: Jul 21, 2027
1 condition1 sponsor189 locations
NCT04665908
PT-led Triage for Patients With Hip o Knee Osteoarthritis
NAActive, not recruiting
675 participants
Started: Oct 26, 2020 · Completed: Dec 31, 2025
2 conditions1 sponsor2 locations
NCT04475939
Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants With Advanced/Metastatic Non-Small Cell Lung Cancer
PHASE3Active, not recruiting
666 participants
Started: Oct 26, 2020 · Completed: Feb 6, 2026
1 condition1 sponsor190 locations
NCT04250545
Testing of the Anti Cancer Drugs CB-839 HCl (Telaglenastat) and MLN0128 (Sapanisertib) in Advanced Stage Non-small Cell Lung Cancer
PHASE1Active, not recruiting
85 participants
Started: Oct 26, 2020 · Completed: Jun 30, 2026
7 conditions1 sponsor7 locations
NCT04291885
Immunotherapy Adjuvant Trial in Patients With Stage I-III Merkel Cell Carcinoma
PHASE2Active, not recruiting
122 participants
Started: Oct 26, 2020 · Completed: Apr 30, 2030
6 conditions1 sponsor20 locations
NCT04598893
Recent-Onset Type 1 Diabetes Extension Study Evaluating the Long-Term Safety of Teplizumab (PROTECT Extension)
N/AActive, not recruiting
188 participants
Started: Oct 26, 2020 · Completed: Nov 30, 2026
1 condition1 sponsor47 locations
NCT03259763
EUS-GE vs ES for Palliation of Gastric Outlet Obstruction
NAActive, not recruiting
112 participants
Started: Oct 26, 2020 · Completed: Mar 14, 2026
1 condition2 sponsors9 locations
NCT04537741
Coronary CT Angiography in Non ST-elevation Myocardial Infarction
NAActive, not recruiting
300 participants
Started: Oct 24, 2020 · Completed: Jun 30, 2027
1 condition8 sponsors8 locations